Effect of MTHFR gene polymorphism impact on atherosclerosis via genome-wide methylation

Medical Science Monitor

Volumn 22, Issue , 2016, Pages 341-345

  Lin, Xuefeng ^a,b,c   Zhang, Wei ^a,b   Lu, Qun ^a,b   Lei, Xinjun ^a,b   Wang, Tingzhong ^a,b   Han, Xuanmao ^c   Ma, Aiqun ^a,b  

^a THE FIRST AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

^b XI'AN JIAOTONG UNIVERSITY   (China)

^c BAOTOU MEDICAL COLLEGE   (China)

Author keywords

4 Nitroquinoline 1 oxide; Atherosclerosis; Multilevel analysis; Polymorphism; Single Stranded conformational

Indexed keywords

GENOMIC DNA; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MTHFR PROTEIN, HUMAN;

ADULT; AGAR GEL ELECTROPHORESIS; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; DNA METHYLATION; DNA POLYMORPHISM; FEMALE; GENE; GENE LOCUS; GENETIC ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; MALE; METHYLENETETRAHYDROFOLATEREDUCTASE GENE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PYROSEQUENCING; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; ENZYMOLOGY; GENE LINKAGE DISEQUILIBRIUM; GENETIC PREDISPOSITION; GENETICS; HUMAN GENOME; LONG INTERSPERSED REPEAT; SINGLE NUCLEOTIDE POLYMORPHISM;

ATHEROSCLEROSIS; DNA METHYLATION; ELECTROPHORESIS, AGAR GEL; FEMALE; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; HUMANS; LINKAGE DISEQUILIBRIUM; LONG INTERSPERSED NUCLEOTIDE ELEMENTS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84957548931     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.895296     Document Type: Article

References (25)

1. Frosst P, Blom HJ, Milos R et al: A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet, 1995; 10: 111-13.
2. Watkins D, Rosenblatt DS: Inborn errors of cobalamin absorption and metabolism. Am J Med Genet C Semin Med Genet, 2011; 157C: 33-44.
3. Montjean D, Benkhalifa M, Dessolle L et al: Polymorphisms in MTHFR and MTRR genes associated with blood plasma homocysteine concentration and sperm counts. Fertil Steril, 2011; 95: 635-40.
4. Karpati I, Balla J, Szoke G et al: [Frequency of hyperhomocysteinemia in hemodialysis patients with folic acid supplementation]. Orv Hetil, 2002; 143: 1635-40.
5. Gecene M, Tuncay F, Borman P et al: Atherosclerosis in male patients with ankylosing spondylitis: the relation with methylenetetrahydrofolate reductase (C677T) gene polymorphism and plasma homocysteine levels. Rheumatol Int, 2013; 33: 1519-24.
6. Ansari R, Mahta A, Mallack E, Luo JJ: Erratum: hyperhomocysteinemia and neurologic disorders: a review. J Clin Neurol, 2015; 11: 106.
7. Paska AV, Hudler P: Aberrant methylation patterns in cancer: a clinical view. Biochem Med (Zagreb), 2015; 25: 161-76.
8. Guardiola M, Vallve JC, Zaina S, Ribalta J: [Epigenetics in atherosclerosis]. Clin Investig Arterioscler, 2015 [Epub ahead of print] [in Spanish].
9. Greissel A, Culmes M, Napieralski R et al: Alternation of histone and DNA methylation in human atherosclerotic carotid plaques. Thromb Haemost, 2015; 114” 390-402.
10. Hiltunen MO, Turunen MP, Hakkinen TP et al: DNA hypomethylation and methyltransferase expression in atherosclerotic lesions. Vasc Med, 2002; 7: 5-11.
11. Lund G, Andersson L, Lauria M et al: DNA methylation polymorphisms precede any histological sign of atherosclerosis in mice lacking apolipoprotein E. J Biol Chem, 2004; 279: 29147-54.
12. Yideng J, Jianzhong Z, Ying H et al: Homocysteine-mediated expression of SAHH, DNMTs, MBD2, and DNA hypomethylation potential pathogenic mechanism in VSMCs. DNA Cell Biol, 2007; 26: 603-11.
13. Weisenberger DJ, Campan M, Long TI et al: Analysis of repetitive element DNA methylation by MethyLight. Nucleic Acids Res, 2005; 33: 6823-36.
14. Yang AS, Estecio MR, Doshi K et al: A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements. Nucleic Acids Res, 2004; 32: e38.
15. Lee SA, Kang D, Nishio H et al: Methylenetetrahydrofolate reductase polymorphism, diet, and breast cancer in Korean women. Exp Mol Med, 2004; 36: 116-21.
16. Chen Q, Sun Y, Zhang L et al: Detection of C677T mutation of MTHFR in subject with coronary heart disease by hairpin probe with enzymatic color on microarray. Biosens Bioelectron, 2011; 28: 84-90.
17. Li JJ, Li Q, Du HP et al: Homocysteine Triggers Inflammatory Responses in Macrophages through Inhibiting CSE-H2S Signaling via DNA Hypermethylation of CSE Promoter. Int J Mol Sci, 2015; 16: 12560-77.
18. Huang YS, Zhi YF, Wang SR: Hypermethylation of estrogen receptor-alpha gene in atheromatosis patients and its correlation with homocysteine. Pathophysiology, 2009; 16: 259-65.
19. Liang Y, Yang X, Ma L et al: Homocysteine-mediated cholesterol efflux via ABCA1 and ACAT1 DNA methylation in THP-1 monocyte-derived foam cells. Acta Biochim Biophys Sin (Shanghai), 2013; 45: 220-28.
20. Zhao L, Jiao Y, Yang AN et al: [The effect of miR-124 on homocysteine-induced atherosclerosis via promoter region DNA methylation in ApoE(-/-) mice]. Sheng Li Xue Bao, 2015; 67: 207-13 [in Chinese].
21. Turunen MP, Aavik E, Yla-Herttuala S: Epigenetics and atherosclerosis. Biochim Biophys Acta, 2009; 1790: 886-91.
22. Szabo GV: The role and importance of gene polymorphisms in the development of atherosclerosis. Interv Med Appl Sci, 2013; 5: 46-51.
23. Zawadzki C, Chatelain N, Delestre M et al: Tissue factor pathway inhibitor-2 gene methylation is associated with low expression in carotid atherosclerotic plaques. Atherosclerosis, 2009; 204: e4-14.
24. Babic Bozovic I, Stankovic A, Zivkovic M et al: Altered LINE-1 Methylation in Mothers of Children with Down Syndrome. PLoS One, 2015; 10: e0127423.
25. Burghardt KJ, Pilsner JR, Bly MJ, Ellingrod VL: DNA methylation in schizophrenia subjects: gender and MTHFR 677C/T genotype differences. Epigenomics, 2012; 4: 261-68.